Effect of Garudan Kizhangu Ennai and Keedari Thailam for Puzhuvettu (Alopecia Areata) in children

Clinical Evaluation of Garudan Kizhangu Ennai (Internal) and Keedari Thailam (External) for the management of Puzhuvettu (Alopecia Areata) in children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043741

Enrollment

Registered

2022-07-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L639- Alopecia areata, unspecified

Interventions

Intervention1: Garudan Kizhangu Ennai (Internal) Keedari Thailam (External): Dosage for Garudan Kizhangu Ennai: 2.5ml - 4ml morning only after food vary with age. Keedari Thailam external use duration

Eligibility

Inclusion criteria

Inclusion criteria: 1.Hair loss in patches. 2.Non-scarring. 3.Scattered long hairs within the bald area. 4.Willing to take photographs whenever required. 5.Patients who are willing to stay in IPD Ward or willing to attend OP Dept. as per schedule. 6.Patient’s informant / Parent willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Scarring alopecia 2.Alopecia universalis 3.Alopecia totalis 4.Vitiligo 5.Atopic dermatitis 6.Tinea capitis 7.Trichotillomania 8.Any other serious illness

Design outcomes

Primary

Measure	Time frame
Effectiveness of the trial drug is measured by Severity of Alopecia Tool (SALT) Score.Timepoint: 45 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr A M Amala Hazel

National Institute of Siddha

dramalaaruldhas@gmail.com9486909809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026